Insider Trading & Ownership - DRACHMAN JONATHAN G

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DRACHMAN JONATHAN G
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-10
Purchase
2021-11-10
7:31 pm
Calithera Biosciences Inc.CALADRACHMAN JONATHAN G
Director
200,000$0.8595$171,900200,000
(Direct)
View
2021-08-24
Purchase
2021-08-26
7:08 pm
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
150,000$6.2237$933,5502,373,686
(Indirect
Direct)
View
2021-06-03
Purchase
2021-06-07
5:06 pm
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
50,000$9.5071$475,3542,248,686
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-08
Option Award
2024-03-11
5:19 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
415$00
(Direct)
View
2024-03-11
Disposition
2024-03-11
5:19 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
14,262$00
(Direct)
View
2023-11-27
Option Award
2023-11-28
4:25 pm
N/A
N/A
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
5,000$05,000
(Direct)
View
2023-06-22
Option Award
2023-06-23
4:32 pm
N/A
2033-06-21
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
23,000$023,000
(Direct)
View
2022-08-02
Option Award
2022-08-04
4:38 pm
N/A
2032-08-01
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
350,000$0350,000
(Direct)
View
2022-06-22
Option Award
2022-06-24
6:45 pm
N/A
2032-06-21
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
10,167$010,167
(Direct)
View
2021-10-26
Ownership
2022-02-14
7:54 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
75,000$02,298,686
(Direct)
View
2021-08-03
Option Award
2021-08-05
4:12 pm
N/A
2031-08-03
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
400,000$0400,000
(Direct)
View
2021-06-11
Option Award
2021-06-14
4:05 pm
N/A
2031-06-10
Calithera Biosciences Inc.CALADRACHMAN JONATHAN G
Director
20,000$020,000
(Direct)
View
2021-05-04
Option Award(A)
2021-05-14
7:59 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
10,167$010,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:53 pm
N/A
2031-05-03
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
10,167$010,167
(Direct)
View
2020-08-10
Option Award
2020-08-12
4:08 pm
N/A
2030-08-10
Neoleukin Therapeutics Inc.NLTXDRACHMAN JONATHAN G
President and CEO
420,000$0420,000
(Direct)
View
2020-06-09
Option Award
2020-06-11
4:01 pm
N/A
2030-06-08
Calithera Biosciences Inc.CALADRACHMAN JONATHAN G
Director
20,000$020,000
(Direct)
View
2020-05-28
Option Award
2020-06-01
9:42 pm
N/A
2030-05-27
Harpoon Therapeutics Inc.HARPDRACHMAN JONATHAN G
Director
13,047$013,047
(Direct)
View
(A) Indicate amendment filing.